For the prevention and treatment of functional intestinal obstruction (PKN): intravenously into the central vein at a rate of 5-10 mg / h, previously dissolving the contents of the ampule (10 mg) in 100-200 ml of physiological saline.When administered to the peripheral vein, 10-20 mg should be dissolved in 200-400 ml of saline. The maximum daily dose can reach 360 mg and above.
Intravenous: 20 to 50 mg are diluted in 200-400 ml of 0.9% sodium chloride solution; injected dropwise (30 cap / min) 2-3 times a day before the appearance or strengthening of weakened peristalsis and clinical manifestations of recovery of motor and evacuation function of the gastrointestinal tract.
For the prevention and treatment of hemorrhagic syndrome associated with Verlhof disease, treatment with isotostics. radiation sickness, malignant neoplasms, hypo- and aplastic anemia, thrombocytopenia, hemorrhagic vasculitis begin with intravenous administration, then switch to intramuscular injections. The initial dose is 5 mg; in the absence of side effects, the dose is increased to 10 mg, not more than 15-20 mg / day. The course of treatment - an average of 10 days.
Intravenous: 5-10 mg of the drug is diluted in 100-150 ml of a 0.9% solution of sodium chloride or in 5-10 ml of a 0.9% solution of sodium chloride, followed by dilution in 100-150 ml of a 5% solution of dextrose (plasma, canned blood) and injected drip (no more than 30 cap / min) no more than 2 times a day.
Intramuscularly: 5 - 10 mg is diluted in 5 ml of a 0.5% solution of lidocaine; Enter 2 times a day at intervals of not less than 4 hours.